Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
about
Human immunodeficiency virus & cardiovascular riskSyphilitic aneurysm of the ascending aortaHuman Immunodeficiency Virus and Heart Failure in Low- and Middle-Income CountriesHIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future researchBurden attributable to Cardiometabolic Diseases in Zimbabwe: a retrospective cross-sectional study of national mortality dataPulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspectiveHypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western KenyaNT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in AfricaHIV-1 subtype C unproductively infects human cardiomyocytes in vitro and induces apoptosis mitigated by an anti-Gp120 aptamer.Heart and HAART: Two sides of the coin for HIV-associated cardiology issuesHuman Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan AfricaEchocardiographic patterns in treatment-naïve HIV-positive patients in Lagos, south-west Nigeria.Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topicEpidemiology of heart failure in sub-Saharan Africa.The Relationship Between HIV Infection and Cardiovascular Disease.Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study.Tuberculous pericarditis with and without HIV.Recent advances in HIV-associated cardiovascular diseases in Africa.HIV and the heart: the impact of antiretroviral therapy: a global perspective.HIV-associated pulmonary arterial hypertension: from bedside to the future.Electrocardiographic abnormalities in treatment-naïve HIV subjects in south-east Nigeria.Acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus.Human immunodeficiency virus-associated heart failure in sub-Saharan Africa: evolution in the epidemiology, pathophysiology, and clinical manifestations in the antiretroviral era.Nucleotide differences of coxsackievirus B3 and chronic myocarditis.Cardiovascular disease in Africa.Pericardial diseases in the era of imaging, biomarkers and molecular diagnosis.Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation.HIV, vascular surgery and cardiovascular outcomes: a South African cohort study.Interventions for treating tuberculous pericarditis
P2860
Q22241184-BE99B296-B653-41B3-9F51-C4D28FC38589Q24632216-4354E6C9-7F0F-48B2-B84C-5DFEB510F23CQ26801331-0A91BC67-5BF1-40B5-B55E-E5E9B7E0DB04Q26827746-751D774E-60A1-4172-A449-0FFE6DBF4D59Q30386690-2A05DA55-7F5E-4364-84E8-28312011AC85Q33899409-5C2AAFE7-20AA-46FE-92A0-F84C8311D5D5Q33968354-00C4E589-CB97-4063-B55F-B086B545DDF0Q34009129-20468D3A-864C-4C87-B7CD-DC5DF0E3D1F2Q34362343-A40EB009-3A60-491E-B46E-5F74779E96CDQ34390565-77CA2712-244C-445E-B62D-183E3E705D09Q35979672-FFABD55E-EE78-486D-B619-8AA6F69F58C0Q36025679-59E5A8D9-C15D-4128-9365-D9D5126D8951Q37073783-3B50ED52-305A-4A17-B27F-E8FE23BA8D2AQ37158108-249C3B91-7B3D-4934-97DF-F5A71F3BFD87Q37390758-494808D6-48DA-4B04-9741-9B0178FCB8C0Q37429096-8554D7FF-5101-45F6-9025-49A387E6D65EQ37660222-5E200848-BE57-44FD-9E11-D11DB67816BAQ37994619-EB922AF8-7975-40E0-9BBF-7E166A282E45Q38107369-0068B76C-8722-494B-BC95-8376BD98F1A9Q38152708-2B5D94D9-7EA5-4E02-9F3A-6375AC5A783AQ38365222-FD0D8C3F-962C-46E4-A230-841281F53346Q38874462-FCB8F66C-6F43-4DE7-8001-12DF11E8C858Q39053751-FCCF3958-138B-46FE-BEAC-563DCCC05FEDQ40073553-1CF4C265-FCCA-4173-A0DE-C85FB32F85BFQ42239289-E3164C0B-8AB5-467A-B5F8-209034123FD3Q42860888-A09740EF-FF5D-4881-A78C-4FF79D73831DQ45902349-30C6B185-7C01-4B82-B027-554166F77A14Q47597201-36C457B0-8CC1-41B8-9E2E-20BF54D99515Q47911148-0A12B641-9909-41A3-9EFF-A818CF00BE81Q56930268-BF507711-B945-40FE-BE19-D3B4D02A9359
P2860
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@ast
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@en
type
label
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@ast
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@en
prefLabel
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@ast
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@en
P1433
P1476
Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.
@en
P2093
James Hakim
P304
P356
10.1161/CIRCULATIONAHA.105.549220
P407
P577
2005-12-01T00:00:00Z